Amelie Eriksson Karlström
Amelie Eriksson Karlström
Professor in Molecular Biotechnology at KTH Royal Institute of Technology
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Surface charge sensitivity of silicon nanowires: Size dependence
N Elfström, R Juhasz, I Sychugov, T Engfeldt, AE Karlström, J Linnros
Nano Letters 7 (9), 2608-2612, 2007
Silicon nanoribbons for electrical detection of biomolecules
N Elfström, AE Karlström, J Linnros
Nano letters 8 (3), 945-949, 2008
Affibody molecules in biotechnological and medical applications
S Ståhl, T Gräslund, AE Karlström, FY Frejd, PÅ Nygren, J Löfblom
Trends in biotechnology 35 (8), 691-712, 2017
99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant Tumors
T Tran, T Engfeldt, A Orlova, M Sandström, J Feldwisch, L Abrahmsén, ...
Bioconjugate chemistry 18 (6), 1956-1964, 2007
Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence
T Engfeldt, A Orlova, T Tran, A Bruskin, C Widström, AE Karlström, ...
European journal of nuclear medicine and molecular imaging 34 (5), 722-733, 2007
Chemical synthesis of triple‐labelled three‐helix bundle binding proteins for specific fluorescent detection of unlabelled protein
T Engfeldt, B Renberg, H Brumer, PÅ Nygren, A Eriksson Karlström
Chembiochem 6 (6), 1043-1050, 2005
99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule
T Engfeldt, T Tran, A Orlova, C Widström, J Feldwisch, L Abrahmsen, ...
European journal of nuclear medicine and molecular imaging 34 (11), 1843-1853, 2007
In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc to Tumor-Targeting Affibody Molecules
T Tran, T Engfeldt, A Orlova, C Widström, A Bruskin, V Tolmachev, ...
Bioconjugate chemistry 18 (2), 549-558, 2007
Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake
T Ekblad, T Tran, A Orlova, C Widström, J Feldwisch, L Abrahmsén, ...
European journal of nuclear medicine and molecular imaging 35 (12), 2245-2255, 2008
Affibody molecules in protein capture microarrays: evaluation of multidomain ligands and different detection formats
B Renberg, J Nordin, A Merca, M Uhlén, J Feldwisch, PÅ Nygren, ...
Journal of proteome research 6 (1), 171-179, 2007
Affibody protein capture microarrays: synthesis and evaluation of random and directed immobilization of affibody molecules
B Renberg, I Shiroyama, T Engfeldt, PÅ Nygren, AE Karlström
Analytical biochemistry 341 (2), 334-343, 2005
Dual labeling of a binding protein allows for specific fluorescence detection of native protein
A Karlström, PÅ Nygren
Analytical biochemistry 295 (1), 22-30, 2001
Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task
A Karlstrom, G Zhong, C Rader, NA Larsen, A Heine, R Fuller, B List, ...
Proceedings of the National Academy of Sciences 97 (8), 3878-3883, 2000
Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of 99mTc-Labeled Anti-HER2 Affibody Molecules
TA Tran, T Ekblad, A Orlova, M Sandström, J Feldwisch, A Wennborg, ...
Bioconjugate chemistry 19 (12), 2568-2576, 2008
A new protecting group for aspartic acid that minimizes piperidine-catalyzed aspartimide formation in Fmoc solid phase peptide synthesis
A Karlström, A Undén
Tetrahedron letters 37 (24), 4243-4246, 1996
Ultra-localized single cell electroporation using silicon nanowires
N Jokilaakso, E Salm, A Chen, L Millet, CD Guevara, B Dorvel, B Reddy, ...
Lab on a Chip 13 (3), 336-339, 2013
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in …
J Malmberg, A Perols, Z Varasteh, M Altai, A Braun, M Sandström, ...
European journal of nuclear medicine and molecular imaging 39 (3), 481-492, 2012
186Re-maSGS-ZHER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumours
A Orlova, TA Tran, T Ekblad, AE Karlström, V Tolmachev
European journal of nuclear medicine and molecular imaging 37 (2), 260-269, 2010
Pre-clinical evaluation of [111In]-benzyl-DOTA-ZHER2: 342, a potential agent for imaging of HER2 expression in malignant tumors
A Orlova, T Tran, C Widström, T Engfeldt, A Eriksson Karlström, ...
International journal of molecular medicine 20 (3), 397-404, 2007
Feasibility of affibody-based bioorthogonal chemistry–mediated radionuclide pretargeting
M Altai, A Perols, M Tsourma, B Mitran, H Honarvar, M Robillard, ...
Journal of Nuclear Medicine 57 (3), 431-436, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20